United States · 
Who invested in Ceptaris Therapeutics?
Ceptaris Therapeutics's investors include SVB Capital, Osage Venture Partners, Burrill & Company, Oxford Finance LLC and Vivo Ventures, and 3 more on record.
2013
$15MDebt$10MSeries DUnited States · Series D startup
Who invested in Ceptaris Therapeutics
Funding summaryUpdated 26 Oct 2026
$25Mraised across 2 rounds since 2012, from 2 sources
$15MDebt$10MSeries D
- Latest round
- Series D, $10MJun 2012
- Biggest round
- $15MDebt · Feb 2012
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $15M Feb 2012
- Biggest round
- $15M Debt · Feb 2012
- Between rounds
- 3 months from the last two
The rounds
- Jun 2012Series D$10M6 new
Osage Venture PartnersBurrill & Company
Vivo Ventures- Aperture Venture Partners
BioAdvance- Palo Alto Investors
Reported by finsmes.comSEC filing: $8.3M sold, first sale May 2012
- Feb 2012Debt$15M2 new
Reported by ceptaris.comSEC filing: $8.3M sold, first sale May 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
AcquiredActelion Pharmaceuticals$250MJul 2013
From historical deal records. Wrong? Tell us.
Everyone who backed them
Aperture Venture PartnersVC firm1round
Palo Alto InvestorsGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ceptaris Therapeutics
How much has Ceptaris Therapeutics raised?
Ceptaris Therapeutics has raised $25M across 2 rounds since 2012.
When did Ceptaris Therapeutics last raise?
Ceptaris Therapeutics's most recent round was a Series D of $10M in Jun 2012.
What was Ceptaris Therapeutics's biggest round?
Ceptaris Therapeutics's largest round on record is $15M (Debt), in Feb 2012.
Who backed Ceptaris Therapeutics first?
Ceptaris Therapeutics's first round on record, in Feb 2012, was backed by SVB Capital and Oxford Finance LLC.
What stage is Ceptaris Therapeutics at?
Ceptaris Therapeutics's latest named round is a Series D, in Jun 2012.
Where is Ceptaris Therapeutics based?
Ceptaris Therapeutics is based in the United States.
Companies like Ceptaris Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.